cisapride has been researched along with Postgastrectomy Syndromes in 5 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Postgastrectomy Syndromes: Sequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (DUMPING SYNDROME and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medical treatment of duodenogastroesophageal reflux in postgastrectomy patients has been disappointing." | 6.68 | Placebo-controlled trial of cisapride in postgastrectomy patients with duodenogastroesophageal reflux. ( Richter, JE; Sears, R; Vaezi, MF, 1996) |
| "Medical treatment of duodenogastroesophageal reflux in postgastrectomy patients has been disappointing." | 2.68 | Placebo-controlled trial of cisapride in postgastrectomy patients with duodenogastroesophageal reflux. ( Richter, JE; Sears, R; Vaezi, MF, 1996) |
| "Postgastrectomy syndromes are uncommon but, unfortunately, frustrating for both patient and physician, because treatment with prokinetic agents is often of limited benefit." | 2.39 | Prokinetic agents in postgastrectomy patients. ( Patterson, DJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patterson, DJ | 1 |
| Vaezi, MF | 1 |
| Sears, R | 1 |
| Richter, JE | 1 |
| Tomita, R | 1 |
| Tanjoh, K | 1 |
| Fujisaki, S | 1 |
| Fukuzawa, M | 1 |
| Campbell, FC | 1 |
| Storey, BE | 1 |
| Cullen, PT | 1 |
| Cuschieri, A | 1 |
| Ricci, DA | 1 |
| McCallum, RW | 1 |
2 reviews available for cisapride and Postgastrectomy Syndromes
| Article | Year |
|---|---|
Prokinetic agents in postgastrectomy patients.
Topics: Bethanechol; Bethanechol Compounds; Cisapride; Domperidone; Erythromycin; Gastric Emptying; Humans; | 1994 |
Diagnosis and treatment of delayed gastric emptying.
Topics: Anemia, Pernicious; Anorexia Nervosa; Cisapride; Connective Tissue Diseases; Diabetes Complications; | 1988 |
1 trial available for cisapride and Postgastrectomy Syndromes
| Article | Year |
|---|---|
Placebo-controlled trial of cisapride in postgastrectomy patients with duodenogastroesophageal reflux.
Topics: Anti-Ulcer Agents; Bilirubin; Cisapride; Cross-Over Studies; Double-Blind Method; Duodenogastric Ref | 1996 |
2 other studies available for cisapride and Postgastrectomy Syndromes
| Article | Year |
|---|---|
Relation between gastroduodenal interdigestive migrating motor complex and postoperative gastrointestinal symptoms before and after cisapride therapy following distal gastrectomy for early gastric cancer.
Topics: Adult; Aged; Cisapride; Duodenum; Female; Gastrectomy; Gastrointestinal Agents; Humans; Male; Middle | 2000 |
Surface vibration analysis (SVA): a new non-invasive monitor of gastrointestinal activity.
Topics: Adult; Cisapride; Diarrhea; Digestive System; Digestive System Physiological Phenomena; Gastrointest | 1989 |